Overview
- 5 inspections across 5 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-02-06.
At a glance
Inspections
5
Sites
5
Observations
0
Career since
Nov 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Vericel Corporation | 6 Feb 2026 | Biologics | On file |
| Bavarian Nordic Berna GmbH | 18 Oct 2024 | Biologics | |
| AGC Biologics SPA | 20 Nov 2023 | Biologics | On file |
| FinVector Oy | 27 Sep 2022 | Biologics | On file |
| Aldevron | 5 Nov 2021 | Biologics |
Sites inspected
Vericel CorporationBurlington, United States1 insp.
Bavarian Nordic Berna GmbHThorishaus, Switzerland1 insp.
AGC Biologics SPABresso, Italy1 insp.
FinVector OyKuopio, Finland1 insp.
AldevronPrairie Rose, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jessica Araujo1 shared
Wen J Seeto1 shared
Zainab Y Mansaray-Storms1 shared
Shufeng Liu1 shared
Robin Levis1 shared
Wei Wang1 shared
Christelle Mbondji Wonje1 shared
Jacob L Bitterman1 shared
Viviana R Ramirez1 shared
Tiffany M Lucas1 shared
Full investigator report
Get the verbatim findings behind Jared D Greenleaf's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site